| Janae Bekker, LPC, NCC | |
|
4489 N Dresden Pl Ste 102, Garden City, ID 83714-5004 | |
| (208) 484-3187 | |
| Not Available |
| Full Name | Janae Bekker |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 4489 N Dresden Pl Ste 102, Garden City, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346874823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LPC-7169 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janae Bekker, LPC, NCC 4489 N Dresden Pl Ste 102, Garden City, ID 83714-5004 Ph: (208) 484-3187 | Janae Bekker, LPC, NCC 4489 N Dresden Pl Ste 102, Garden City, ID 83714-5004 Ph: (208) 484-3187 |
News Archive
Gender-sensitized lifestyle programs delivered in professional football clubs have shown promise in increasing physical activity in Europe and could play an important public health role in engaging underserved men, according to a study published February 5 in the open-access journal PLOS Medicine by Sally Wyke of the University of Glasgow, and colleagues.
Researchers from Regenstrief Institute and Indiana University are building and expanding global relationships and collaborations in the fields of public health and health informatics.
IAOCR, the leading provider of independently recognized, competence-based accreditation, consultancy and accredited training within the clinical research sector, is pleased to announce the pilot Clinical Operations Workforce Quality Accreditation, achievement of which will serve as a quality mark for clinical operations workforce excellence. Leading contract research organization (CRO) INC Research is the first to participate in the pilot, introduced to industry specialists at the annual IAOCR Clinical Research Industry Leaders Think Tank in June.
Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial. The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia™ System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients.
› Verified 7 days ago
Jennifer Weseman, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 175 E 50th St, Garden City, ID 83714 Phone: 208-917-1863 Fax: 208-906-0815 | |
Ms. Ingri Suzanne Koloski, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8969 West Hepburn Lane, Garden City, ID 83714 Phone: 208-972-4981 | |
Mrs. Donna Maxine Williams, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 215 W 35th St, Garden City, ID 83714 Phone: 208-570-1200 | |
Rachel Ford, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4822 W Mystic Cove Way, Garden City, ID 83714 Phone: 662-299-3703 | |
Hailey Townsend, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 175 E 50th St, Garden City, ID 83714 Phone: 208-991-3027 | |
Ashleigh Griffin, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 175 E 50th St, Garden City, ID 83714 Phone: 208-754-5142 |